Tyrosine and Drug-like Late-stage Benzylic Functionalization via Photoredox Catalysis

doi:10.21203/rs.3.rs-93319/v1

PDF

Article

Tyrosine and Drug-like Late-stage Benzylic Functionalization via Photoredox Catalysis

https://doi.org/10.21203/rs.3.rs-93319/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted 26 Oct, 2020

You are reading this latest preprint version

Visible light mediated late-stage functionalization is a rising field in synthetic and medicinal chemistry, allowing the fast and diversified modification of valuable, potentially therapeutic compounds such as peptides. However, there are relatively few mild methodologies for the C(sp³)-H functionalization of complex peptides. Herein, we report a visible light mediated photocatalytic protocol for the benzylic C-H modification of tyrosine and related C-H bonds. The embraced radical-cation/deprotonation strategy enables an incorporation of a wide range of valuable functional groups in high yields and chemoselectivity. The mild reaction conditions, site-selectivity and high functional group tolerance was highlighted by the functionalization of complex peptides, drugs and natural products, providing a promising synthetic platform in medicinal chemistry.

Catalysis

Organic Chemistry

Visible light mediated late-stage functionalization

photoredox catalysis

C(sp3)-H functionalization

Late-stage functionalization (LSF) of C-H bonds, which enables the incorporation of functional groups at the end of a synthesis sequence or in natural products, is an emerging field in organic synthesis and drug discovery.^1–3 The rapid access to structurally diverse chemical series has a significant impact on the time and cost consuming optimization of clinical candidates in drug discovery.³ Nevertheless, due to the ubiquity of C-H bonds, the chemo- and site-selectivity are still major challenges in LSF.⁴ Recently, LSF via photoredox catalysis has gained great attention.^5–8 In this regard, various selective photocatalyzed LSF methodologies, e.g. for the functionalization of C(sp²)-H bonds,^9–10 α-heteroatom positions,^11–13 or decarboxylation reactions,^14–15 have been developed. However, benzylic photocatalyzed LSF is significantly underrepresented.⁵ In particular, the benzylic functionalization of electron rich compounds such as in tyrosine or other phenolic drug-like derivatives is highly appealing, since this type benzylic C-H bonds are ubiquitous in biomolecules and pharmaceuticals (Fig. 1, a).¹⁶

A commonly used approach in photoredox C-H functionalization relies on hydrogen atom transfer (HAT),^17–25 in which a photocatalytically generated radical species is able to abstract a hydrogen atom from the substrate. However, C-H bond discrimination issues often lead to a poor site-selectivity for benzylic positions.⁵ In fact, other C-H bonds like in tertiary or α-heteroatom positions are modified under similar HAT conditions, which compromises the potential for benzylic LSF.^23–26 Therefore, alternative methods to overcome the current reactivity and selectivity issues are highly demanded. On course of our research program on amino acid and peptide modification,^13,27−28 we imagined that a photocatalytic radical-cation/deprotonation strategy^29–33 could be employed as a more promising technique for the selective functionalization of tyrosine derivatives, as well as related phenolic drugs (Fig. 1, b). In this approach, a reactive radical cation is formed upon single electron transfer (SET) to the excited photocatalyst. Due to a significant increased acidity of the benzylic position in the radical cationic species (pk_A ~ − 13),³⁴ a deprotonation to form a benzylic radical is possible, which can then be further modified by reaction with a suitable acceptor. The selectivity of the method strongly depends on the redox potentials of the photocatalyst and the substrate, and thus a predictable site activation can be achieved.

Although, this strategy has been efficiently employed in benzylic C(sp³)-H modifications of simple substrates,^29–33 it has been long neglected for LSF.^35–37 Thus, a late-stage C-C coupling of electron-rich benzylic positions is unknown embracing this promising methodology. Taking all into account, the development of a novel site-selective LSF methodology of phenol-type structures is highly desirable as it would represent a powerful tool in synthetic and medicinal chemistry. Hence, we herein present a mild photocatalytic functionalization methodology of benzylic C-H bonds in tyrosine derivatives, which can be extended for LSF to other related C-H bonds in peptides and tyrosine-like phenolic drugs and natural products

Reaction Optimization

In this regard, we started our studies with the examination of the reaction of N-acetyl tyrosine methyl ester (1, E_p/2= + 1.58 V vs SCE in CH₃CN, see S.I.) as the model substrate with methyl acrylate (2a) as the radical acceptor in acetonitrile at room temperature upon irradiation with blue LEDs in a photoreactor (Table 1; see S.I. for full screening). As expected, the control experiments without catalyst and/or light were negative, illustrating the need of a photoredox catalyst (entry 1). Therefore, a preliminary screening of photocatalysts was made, showing that photosensitizers with a redox potential slightly above of the one of tyrosine were more effective. In particular, the iridium-based photocatalysts with the dCF₃bpy ligand (E*_p/2 = +1.65 V³⁸ and +1.68 V³⁸ vs SCE for PC5 and PC6, respectively) led to the best results (entries 6 and 7), while diminished conversions were obtained with the acridinium PC2 (E*_p/2 = +1.65 V vs SCE)³⁹ (entry 3). Photocatalysts with significant higher potentials like the Fukuzumi catalyst (PC1, +2.06 V vs SCE;³⁹ entry 2) or with potentials below of the tyrosine like 4-CzIPN (PC3, E*_p/2 = +1.43 V vs SCE;⁴⁰entry 4) or Ir-4,4´-dtbpy (PC4, E*_p/2 = +1.21 V vs SCE;⁴¹ entry 5) showed no conversion. Systematic reaction screening led to the identification of [Ir(dFCF₃ppy)₂(4,4´-dCF₃bpy)]PF₆(PC5) (2 mol%) in CH₂Cl₂(0.2 M) as the optimal system (entry 9). However, side product analysis revealed the dimerization of the tyrosine and oligomerization of methyl acrylate as major side-reactions. The observed oligomerization side reactions indicated an ineffective closing of catalytic cycle (E_p/2 = -0.79 V vs SCE).³⁸ Therefore, to hamper the dimerization reaction, the radical acceptor loading was increased to 5.0 equivalents (entry 10). Although only a slightly improvement in the yield (from 41 to 48%) was achieved, the formation of the dimerization product was drastically suppressed.

Table 1: Optimization studies for the benzylic C-H alkylation of tyrosine derivative 1.^a

Entry	Photocatalyst (PC)	Solvent (M)	Conversion (%)^b
1	No light or no PC	CH₃CN (0.1)	0
2	PC1	CH₃CN (0.1)	0
3	PC2	CH₃CN (0.1)	5
4	PC3	CH₃CN (0.1)	0
5	PC4	CH₃CN (0.1)	0
6	PC5	CH₃CN (0.1)	30
7	PC6	CH₃CN (0.1)	21
8	PC5	CH₂Cl₂ (0.1)	36
9	PC5	CH₂Cl₂ (0.2)	41
10	PC5	CH₂Cl₂ (0.2)	48^c

^a Reactions conducted using 0.05 mmol of 1 in degassed solvents and irradiated for 24 h in a HepatoChem PhotoRedOx Box. ^b Conversion determined by LC-MS. ^c5.0 equivalents of 2a were used.

Functionalization of tyrosine derivatives.

With the optimized conditions in hand (2 mol% PC5 and 5.0 equiv. radical acceptor in 0.2 M CH₂Cl₂under blue light irradiation at 20 °C), different radical acceptors were next explored with 1 as substrate (Fig. 2, a). Aiming at further improving the conversion of this process, the more reactive radical acceptor 1,1-bis(phenylsulfonyl)ethylene (2b) was first explored. Pleasantly, the desired product was afforded in an excellent yield of 96% and a good diastereomeric ratio (d.r. 3:1). Moreover, no oligomerization was observed and only low amounts of difunctionalized product was formed after elongated reaction time. The configuration of the major diastereoisomer of product 3b was determined as (2S,3S) by NOESY experiments (see S.I.). Similarly, other activated alkenes like benzylidene malonitrile (2c) or electron acceptors with aryl sulfonyl leaving groups 2d-f ^42-44 could be efficiently enrolled in the reaction. As a result, valuable cyano, allyl and alkynyl groups could be selectively introduced in excellent yields (up to 96%) and good diastereoselectivities (up to 6:1 d.r).

Considering the importance of orthogonal protecting group strategies in peptide chemistry,⁴⁵ the influence of different protecting groups often used in medicinal chemistry and drug-target discovery was studied next (Fig. 2, b). Alkylic O-protecting groups, such as methyl, tert-butyl or benzyl afforded the benzylic substitution products in excellent yields (3-5, up to 96%). In case of the O-silyl protection (TBS), a synthetically useful yield of 69% (6b), was observed. N-acyl protecting groups like acetyl or carbamates such as Boc, Fmoc or Cbz were well tolerated, leading to the desired products 7-9 in good yields. Additional to methyl esters, tert-butyl and benzyl esters were also accepted, providing the products in excellent yields (10b and 11b, 87 and 91%, respectively).

The synthetic utility of the methodology was subsequently illustrated with synthesis of novel tyrosine amino acids by derivatization of the bissulfonyl product 3b (Fig. 2, c). Tyrosine 12 was obtained in an excellent 93% yield after deprotection of the methyl ether upon addition of TMSI. Moreover, the reductive desulfonylation by the Mg/MeOH system afforded the ethyl tyrosine analogue 15 in 84% yield and with no change in the diastereomeric ratio. By fluorination of 3b with selectfluor prior to the reduction, valuable mono-fluorinated ethyl tyrosine 16 was obtained in a good yield. The bisphenylsulfonyl group could be also converted to an ester moiety by oxidation with mCBPA, which cyclizes to the lactame 14.

Functionalization of tyrosine-containing peptides

Next, the methodology was investigated for the functionalization of complex tyrosine-containing peptides (Fig. 3). In this regard, a selective tyrosine functionalization in benzylic position was obtained in good to excellent yields in peptides with up to 8 amino acid units. Other possible reactive sites like tertiary C-H bonds (Val, Ile, Leu), other benzylic positions (Phe), α-to heteroatom positions (Pro, Lys, Thr) or αC-H glycine bonds remained untouched under the applied conditions, which provides a complementary strategy to previous reported HAT functionalization approaches.^13,23,26 Noteworthy, the configuration analysis on dipeptides revealed an opposite configuration at the newly formed stereocenter compared to the single amino acid 3b. Hence, the major isomer of the dipeptide 17b was determined as the (2S, 3R) (see S.I.). Moreover, other alkyl and alkynyl functional groups could also be introduced in moderate to very good yields.

Late-stage benzylic functionalization of drugs

Considering that tyrosine is an important metabolic precursor,^46-48 especially in the synthesis of neurotransmitters (dopamine, adrenaline, etc.) or other secondary metabolites, we were interested in applying our methodology directly to this type of substrates (Fig. 4). To our delight, dopamine and the Parkinson drug L-Dopa were converted to the corresponding products 22 and 23 in excellent yields. Moreover, due to a higher observed reactivity, the amount of radical acceptor could be decreased to 3.0 equivalents.

Additionally, unnatural α-aryl substituted derivatives can also participate in this reaction upon elongated reaction times (≥72 h). Consequently, α-quaternary carbon containing compounds such as 24b could be obtained in good yield. Furthermore, natural products like the opium alkaloid papaverine or the secondary metabolite catechin were successfully modified under these conditions, providing the alkylated products 25c and 26b in good to very good yields. Interestingly, the catechin analogue was obtained as a single diastereomer with exclusive functionalization of the secondary benzylic center. Aiming at a broader applicability, we further focused our attention to additional phenol moieties, which are encountered in many dugs. In this regard, blockbuster drugs, like gemfibrozil or indomethacin, and the insecticide etofenprox were transformed to the corresponding products 27-29 in good to excellent yields. In case of the functionalization of primary benzylic positions (gemfibrozil and indomethacin), the amount of radical acceptor was decreased to 1.1 or 1.5 equivalents in order to prevent dialkylation. Moreover, a selectivity control was also observed from the used radical acceptor. Consequently, the reaction of the sterically hindered benzyliden malonitrile (2c) with indomethacin showed exclusive mono-functionalization of the primary, electronically richer position (product 28c). A similar observation was made in the modification of gemfibrozil presenting two primary benzylic positions. A favored functionalization of the more activated ortho over the meta methyl group was observed with 2c (product 27c). However, a small amount of the less favored meta-benzylic alkylation was observed with the more reactive bissulfonyl alkene 2b (27b, r.r. >18:1).

Mechanistic investigation

Finally, aiming at shedding some light into the photoredox catalytic process of this reaction, mechanistic investigations were carried out. Stern-Volmer quenching experiments showed a strong interaction of the excited photocatalyst with the tyrosine derivative 1 and no quenching with the alkene 2b (Fig. 5). Interestingly, the product 3b was found to be a good quencher too, though no difunctionalized products could be detected. Presumably, the possible di-functionalization is suppressed due to steric effects. Additionally, a low quantum yield (F) of 0.03 was measured (see S.I.), which might most likely exclude a radical chain reaction.

Taking all the previous observations into account, a proposed mechanism for the photocatalytic oxidative C-H functionalization of tyrosine with alkenes as radical acceptors is outlined in Fig. 6. Upon light excitation of the photoredox catalyst, tyrosine is oxidized to the corresponding radical cation II by single electron transfer to the excited photocatalyst [Ir*], following a reductive quenching cycle. Next, deprotonation of II to form the benzylic radical III, followed by radical addition to the alkene lead to the radical intermediate IV. The catalytic cycle is closed by electron transfer from the reduced photocatalyst species [Ir^•–] to the radical IV, forming the anionic species V. Then, the final product VI is obtained after protonation. In order to determine the source of protons for this last step, the reaction was performed in deuterated dichloromethane. However, no deuterium incorporation in the product was observed, indicating the tyrosine substrate as the proton source.

In summary, we have developed a novel visible light-mediated functionalization strategy of electron-rich benzylic C-H bonds in tyrosine containing peptides and drug-like compounds. In this photoredox catalyzed radical-cation/deprotonation approach, a broad range of valuable functional groups could be selectively introduced into the tyrosine backbone. The combination of mild reaction conditions, chemoselectivity and functional group tolerance was highlighted by the late-stage functionalization of complex peptides, drugs and natural products. Hence, the demonstrated mild and selective generation of benzyl radicals in complex molecule scaffolds provides a powerful strategy with broad applicability in synthetic and medicinal chemistry.

General procedure for the photocatalytic reaction

In an oven-dried screw-cap vial, [Ir(dF(CF₃)ppy)(4,4´-dCF₃bpy)]PF₆ (PC5) (2.3 mg, 0.002 mmol, 2 mol%), the substrate (0.1 mmol, 1.0 equiv.) and the radical acceptor (1.1–5.0 equiv.) were dissolved in 0.5 mL dry CH₂Cl₂ (0.2 M). The mixture was degassed by bubbling argon for several minutes and the vial was sealed. The reaction mixture was irradiated by blue LEDs (max. 415 nm) for 18–72 h (the reaction progress was monitored by LC-MS or TLC). The crude was purified by flash column chromatography.

The authors declare that the data supporting the findings of this study are available within the article and Supplementary Information file, and also are available from the corresponding author upon reasonable request.

Acknowledgements (optional)

INTERREG V A, ETZ 2014-2020 – Bayern-Czech Republic (project 41) is gratefully acknowledged for generous support. We want to thank Remo Weck for experimental support.

Ethics declarations

Competing interests

The authors declare no competing financial interest.

Cernak, T., Dykstra, K. D., Tyagarajan, S., Vachal, P. & Krska, S. W. The medicinal chemist's toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 45, 546-576 (2016).
Moir, M., Danon, J. J., Reekie, T. A. & Kassio, M. An overview of late-stage functionalization in today's drug discovery. Expert Opin. Drug Discov. 14, 1137-1149 (2019).
Boström, J., Brown, D. G., Young, R. J. & Keserü, G. M. Expanding the medicinal chemistry synthetic toolbox. Nat. Rev. 17, 709-727 (2018).
Valeur, E., Guéret, S. M., Adihou, H.; Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N. & Plowright, A. T. New Modalities for Challenging Targets in Drug Discovery. Angew. Chem. Int. Ed. 56, 10294-10323 (2017).
Capaldo, L., Quadri, L. L. & Ravelli, D. Photocatalytic hydrogen atom transfer: the philosopher's stone for late-stage functionalization? Green Chem. 22, 3376-3396 (2020).
Bottecchia, C.; & Nol, T. Photocatalytic Modification of Amino Acids, Peptides, and Proteins. Chem. Eur. J. 25, 26-42 (2019).
Liu, J.-Q., Shatskiy, A., Matsuura, B. S. & Kärkäs, M. D. Recent Advances in Photoredox Catalysis Enabled Functionalization of α-Amino Acids and Peptides: Concepts, Strategies and Mechanisms. Synthesis 51, 2759-2791 (2019).
C. R. J. Stephenson, T. P. Yoon & D. W. C. MacMillan in Visible Light Photocatalysis in Organic Chemistry (Wiley-VCH, 2018).
DiRocco, D. A., Dykstra, K., Krska, S., Vachal, P., Conway, D. V. & Tudge, M. Late‐Stage Functionalization of Biologically Active Heterocycles Through Photoredox Catalysis. Angew. Chem. Int. Ed. 53, 4802-4806 (2014).
Ichiishi, N., Caldwell, J. P., Lin, M., Zhong, W., Zhu, X., Streckfuss, E., Kim, H.-J., Parish, C. A. & Krska, S. W. Protecting group free radical C–H trifluoromethylation of peptides. Chem. Sci. 9, 4168-4175 (2018).
Loh, Y. Y., Nagao, K., Hoover, A. J., Hesk, D., Rivera, N. R., Colleti, S. L., Davies, I. W. & MacMillan, D. W. C. Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds. Science 358, 1182-1187 (2017).
Yilmaz, O., Oderinde, M. S. & Emmert, M. H. Photoredox-Catalyzed C_α–H Cyanation of Unactivated Secondary and Tertiary Aliphatic Amines: Late-Stage Functionalization and Mechanistic Studies. J. Org. Chem. 83, 11089-11100 (2018).
Legros, F., Fernandez-Rodriguez, P., Mishra, A., Weck, R., Bauer, A., Sandvoss, M., Ruf, S., Méndez, M., Mora-Radó, H., Rackelmann, N., Pöverlein, C. & Derdau, V. Photoredox-mediated Hydrogen Isotope Exchange Reactions of Amino-Acids, Peptides and Peptide-derived drugs. Chem. Eur. J. 26, 12738-12742, (2020).
Sakkakibara, Y., Ito, E.; Fukushima, T., Murakami, K. & Itami, K. Late‐Stage Functionalization of Arylacetic Acids by Photoredox‐Catalyzed Decarboxylative Carbon–Heteroatom Bond Formation. Chem. Eur. J. 24, 9254-9258 (2018).
Bloom, S., Liu, C., Kölme, D. K., Qiao, J. X., Zhang, Y., Poss, M. A., Erwing, W. R. & MacMillan, D. W. C. Decarboxylative alkylation for site-selective bioconjugation of native proteins via oxidation potentials. Nat. Chem. 10, 205-211 (2018).
McGrath, N. A., Brichacek, M. & Nijardarson, J. T. A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives. J. Chem. Ed. 87, 1348-1349 (2010).
Xia, J.-B., Zhu, C. & Chen, C. Visible Light-Promoted Metal-Free C–H Activation: Diarylketone-Catalyzed Selective Benzylic Mono- and Difluorination. J. Am. Chem. Soc. 135, 17494-17500 (2013).
Li, F., Tian, D., Fan, Y., Lee, R., Lu, G., Yin, Y., Qiao, B.; Zhao, X., Xiao, Z. & Jiang, Z. Chiral acid-catalysed enantioselective C−H functionalization of toluene and its derivatives driven by visible light. Nat. Commun. 10, 1774 (2019).
Dewanji, A., Krach, P. E. & Rueping, M. The Dual Role of Benzophenone in Visible‐Light/Nickel Photoredox‐Catalyzed C−H Arylations: Hydrogen‐Atom Transfer and Energy Transfer. Angew. Chem. Int. Ed. 58, 3566-3570 (2019).
Cheng, X., Lu, H. & Lu, Z. Enantioselective benzylic C–H arylation via photoredox and nickel dual catalysis. Nat. Commun. 10, 3549-3556 (2019).
Tanaka, H., Sakai, K., Kawamura, A., Oisaki, K. & Kanai M. Sulfonamides as new hydrogen atom transfer (HAT) catalysts for photoredox allylic and benzylic C–H arylations. Chem Commun. 54, 3215-3218 (2018).
Li, Y., Lei, M. & Gong, L. Photocatalytic regio- and stereoselective C(sp³)–H functionalization of benzylic and allylic hydrocarbons as well as unactivated alkanes. Nat. Catal. 2, 1016-1026 (2019).
Bume, D. D., Pitts, C. R., Jokhai, R. T. & Lectka, T. Direct, visible light-sensitized benzylic C-H fluorination of peptides using dibenzosuberenone: selectivity for phenylalanine-like residues. Tetrahedron 72, 6031-6036 (2016).
Margrey, K. A., Czaplyski, W. L., Nicewicz, D. A.; & Alexanian, E. J. A General Strategy for Aliphatic C–H Functionalization Enabled by Organic Photoredox Catalysis. J. Am. Chem. Soc. 140, 4213-4217 (2018).
Morton, C. M., Zhu, Q., Ripberger, H., Troian-Gautier, L., Toa, Z. S. D., Knowles, R. R. & Alexanian, E. J. C–H Alkylation via Multisite-Proton-Coupled Electron Transfer of an Aliphatic C–H Bond. J. Am. Chem. Soc. 141, 13253-13260 (2019).
Le, C., Liang, Y., Evans, R. W., Li, X. & MacMillan, D. W. C. Selective sp³ C–H alkylation via polarity-match based cross-coupling. Nature 547, 79-83 (2017).
Brandhofer, T. & García Mancheño, O. Versatile Ru‐Photoredox‐Catalyzed Functionalization of Dehydro‐Amino Acids and Peptides. ChemCatChem 11, 3797-3801 (2019).
Brandhofer, T. & García Mancheño, O. Site‐Selective C–H Bond Activation/Functionalization of Alpha‐Amino Acids and Peptide‐Like Derivatives. Eur. J. Org. Chem. 44, 6050-6067 (2018).
Ohku, K., Mizushima, K., Iwata, R., Souma, K., Suzuki, N. & Fukuzumi, S. Simultaneous production of p-tolualdehyde and hydrogen peroxide in photocatalytic oxygenation of p-xylene and reduction of oxygen with 9-mesityl-10-methylacridinium ion derivatives. Chem. Commun. 46, 601-603 (2010).
Zhou, R., Liu, H.-W., Tao, H.-R., Yu, X.-J. & Wu, J. Metal-free direct alkylation of unfunctionalized allylic/benzylic sp³ C–H bonds via photoredox induced radical cation deprotonation. Chem. Sci. 8, 4654-4659 (2017).
Liu, H., Ma, L., Zhou, R., Chen, X., Fang, W. & Wu, J. One-Pot Photomediated Giese Reaction/Friedel–Crafts Hydroxyalkylation/Oxidative Aromatization to Access Naphthalene Derivatives from Toluenes and Enones. ACS Catal. 8 6224-6229 (2018).
Betori, R. C., May, C. M. & Scheidt, K. A. Combined Photoredox/Enzymatic C−H Benzylic Hydroxylations. Angew. Chem. Int. Ed. 58, 16490-16496 (2019).
Zhang, L., Yi, H., Wang, J. & Lei, A. Visible-light induced oxidative Csp³–H activation of methyl aromatics to methyl esters. Green Chem. 18, 5122-5126 (2016).
Nicholas, A. M. P. & Arnold, D. R. Thermochemical parameters for organic radicals and radical ions. Part 1. The estimation of the pK, of radical cations based on thermochemical calculations. Can. J. Chem. 60, 2165-2179 (1982).
Joo Lee, B., DeGlopper, K. S. & Yoon, T. P. Site‐Selective Alkoxylation of Benzylic C−H Bonds by Photoredox Catalysis. Angew. Chem. Int. Ed. 59, 197-202 (2020).
Xu, W., Wang, W., Liu, T., Xie, J. & Zhu, C. Late-stage trifluoromethylthiolation of benzylic C-H bonds. Nat. Commun. 10, 4867-4875 (2019).
Yu, Y., Zhang, L.-K., Buevich, A. V., Li, G., Tang, H., Vachal, P.; Colletti, S. L. & Shi, Z.-C. Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position Conjugation. J. Am. Chem. Soc. 140, 6797-6800 (2018).
Choi, G. J., Zhu, Q., Miller, D. C., Gu, C. J. & Knowles, R. R. Catalytic alkylation of remote C–H bonds enabled by proton-coupled electron transfer. Nature 539, 268-271 (2016).
Joshi-Pangu, A., Lévesque, F., Roth, H. G., Oliver, S. F., Campeau, L.-C., Nicewicz, D. & DiRocco, D. A. Acridinium-Based Photocatalysts: A Sustainable Option in Photoredox Catalysis. J. Org. Chem. 81, 7244-7249 (2016).
Speckmeier, E., Fischer, T. G. & Zeitler, K. A Toolbox Approach to Construct Broadly Applicable Metal-Free Catalysts for Photoredox Chemistry: Deliberate Tuning of Redox Potentials and Importance of Halogens in Donor–Acceptor Cyanoarenes. J. Am. Chem. Soc. 140, 15353-15365 (2018).
Luo, J. & Zhang, J. Donor-Acceptor Fluorophores for Visible-Light-Promoted Organic Synthesis: Photoredox/Ni Dual Catalytic C(sp³)-C(sp²) CrossCoupling. ACS Catal. 6, 873-877 (2016).
Heitz, D. R., Rizwan, K. & Molander, G. A. Visible-Light-Mediated Alkenylation, Allylation, and Cyanation of Potassium Alkyltrifluoroborates with Organic Photoredox Catalysts. J. Org. Chem. 81, 7308-7313 (2016).
Jiang, M., Jin, Y., Yang, H. & Fu, H. Visible-light photoredox synthesis of unnatural chiral α-amino acids. Sci. Rep. 6, 26161-26169 (2016).
Wakaki, T., Sakai, K., Enomoto, T., Kondo, M., Masaoka, S., Oisaki, K. & Kanai, M. C(sp³)-H Cyanation Promoted by Visible‐Light Photoredox/Phosphate Hybrid Catalysis. Chem. Eur. J. 24, 8051-8055 (2018).
Isidro-Llobet, A., Àlvarez, M. & Alberico, F. Amino Acid-Protecting Groups. Chem. Rev. 109, 2455-2504 (2009).
Parthasarathy, A., Cross, P. J., Dobson, R. C. J., Adams, L. E., Savka, M. A. & Hudson, A. O. A Three-Ring Circus: Metabolism of the Three Proteogenic Aromatic Amino Acids and Their Role in the Health of Plants and Animals. Front. Mol. Biosci. 5, 29 (2018).
Tonks, N. K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7, 833-846 (2006).
Lee, J., Ju, M., Cho, O. H., Kim, Y. & Nam, K. T. Tyrosine‐Rich Peptides as a Platform for Assembly and Material Synthesis. Adv. Sci. 6, 1801255-1801270 (2019).

There is NO Competing Interest.

SupportingInformation.pdf
Supplementary Information is supplied as a separate PDF file and includes: • Detailed experimental procedures, characterization of chemical compounds, electrochemical data and NMR spectra

PDF

Version 1

posted 26 Oct, 2020

You are reading this latest preprint version

Tyrosine and Drug-like Late-stage Benzylic Functionalization via Photoredox Catalysis

Status:

Version 1

Abstract

Figures

Introduction

Results

Discussion

Methods

Data Availability

Declarations

References

Competing Interests

Supplementary Files

Status:

Version 1